Location History:
- Tres Cantos-Madrid, ES (2020 - 2022)
- Madrid, ES (2014 - 2024)
Company Filing History:
2 out of 12 
2 out of 1,178 
1 out of 6 Years Active: 2014-2024
Title: The Innovative Contributions of Eleuterio Lombardo
Introduction
Eleuterio Lombardo, an esteemed inventor based in Tres Cantos, Madrid, Spain, has made significant strides in the field of biotechnology. With five patents to his name, Lombardo's research focuses on stem cell therapies, particularly concerning exosomes derived from mesenchymal stem cells. His innovative inventions showcase his dedication to advancing medical science and addressing complex health issues.
Latest Patents
Lombardo's latest patents highlight his groundbreaking work in cell therapy. One of his notable inventions, "Mesenchymal stem cell-derived exosomes and their uses," details the development of exosomes from mesenchymal stem cells and methods for isolating these populations. This invention has crucial implications for creating pharmaceutical compositions aimed at treating immune-mediated inflammatory diseases.
Another significant patent is "Lymphocyte biomarkers for determining the clinical response to cell therapy." This invention provides a method for assessing the clinical prognosis of human subjects receiving stem cell-based therapies. By utilizing biomarkers, this method enhances the efficacy and safety of treatments involving various cellular components, including mesenchymal stem cells, stromal cells, and regulatory T-cells.
Career Highlights
Throughout his career, Eleuterio Lombardo has been associated with prominent companies in the pharmaceutical and biotech sectors. He has worked for Tigenix S.A.U., a key player in the development of regenerative medicine, and Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His experiences in these organizations have undoubtedly contributed to his innovative thinking and patentable ideas.
Collaborations
In his professional journey, Lombardo has collaborated with esteemed colleagues such as Olga De La Rosa and Wilfried Dalemans. These partnerships have fostered an environment of creativity and shared expertise, which has been instrumental in the development of Lombardo's patents and contributions to the field.
Conclusion
Eleuterio Lombardo's work reflects a profound commitment to advancing medical technology through the innovation of stem cell therapies. His contributions, marked by five patents, position him as a significant figure in the biotechnology landscape. With ongoing research and collaboration, Lombardo's inventions hold the potential to transform treatment protocols for various diseases, paving the way for future breakthroughs in regenerative medicine.